Xtant Medical Holdings Inc (NYSE MKT:XTNT) — Market Cap & Net Worth
Market Cap & Net Worth: Xtant Medical Holdings Inc (XTNT)
Xtant Medical Holdings Inc (NYSE MKT:XTNT) has a market capitalization of $67.23 Million ($67.23 Million) as of July 21, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #20716 globally and #4641 in its home market, demonstrating a 2.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xtant Medical Holdings Inc's stock price $0.48 by its total outstanding shares 140068260 (140.07 Million). See Xtant Medical Holdings Inc (XTNT) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Xtant Medical Holdings Inc Market Cap History: 2015 to 2026
Xtant Medical Holdings Inc's market capitalization history from 2015 to 2026. Data shows change from $4.71 Billion to $67.23 Million (-34.15% CAGR).
Xtant Medical Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xtant Medical Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.82x
Xtant Medical Holdings Inc's market cap is 0.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.97x
Xtant Medical Holdings Inc's market cap is 21.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $924.45 Million | $90.00 Million | -$19.49 Million | 10.27x | N/A |
| 2017 | $962.27 Million | $82.61 Million | -$52.41 Million | 11.65x | N/A |
| 2018 | $225.51 Million | $72.20 Million | -$70.10 Million | 3.12x | N/A |
| 2019 | $224.11 Million | $64.68 Million | -$8.22 Million | 3.46x | N/A |
| 2020 | $167.54 Million | $53.34 Million | -$7.02 Million | 3.14x | N/A |
| 2021 | $78.44 Million | $55.26 Million | -$4.85 Million | 1.42x | N/A |
| 2022 | $92.45 Million | $57.97 Million | -$8.48 Million | 1.59x | N/A |
| 2023 | $158.28 Million | $91.30 Million | $660.00K | 1.73x | 239.81x |
| 2024 | $62.05 Million | $117.27 Million | -$16.45 Million | 0.53x | N/A |
| 2025 | $109.25 Million | $133.93 Million | $4.97 Million | 0.82x | 21.97x |
Competitor Companies of XTNT by Market Capitalization
Companies near Xtant Medical Holdings Inc in the global market cap rankings as of July 21, 2026.
Key companies related to Xtant Medical Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $176.77 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $122.13 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #235 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #240 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $176.77 Billion | $101.66 |
| #196 | Stryker Corporation | NYSE:SYK | $122.13 Billion | $319.14 |
| #235 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $83.29 |
Xtant Medical Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Xtant Medical Holdings Inc's market cap moved from $4.71 Billion to $ 67.23 Million, with a yearly change of -34.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $67.23 Million | -38.46% |
| 2025 | $109.25 Million | +76.07% |
| 2024 | $62.05 Million | -60.80% |
| 2023 | $158.28 Million | +71.21% |
| 2022 | $92.45 Million | +17.86% |
| 2021 | $78.44 Million | -53.18% |
| 2020 | $167.54 Million | -25.24% |
| 2019 | $224.11 Million | -0.62% |
| 2018 | $225.51 Million | -76.56% |
| 2017 | $962.27 Million | +4.09% |
| 2016 | $924.45 Million | -80.36% |
| 2015 | $4.71 Billion | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of Xtant Medical Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $67.23 Million USD |
| MoneyControl | $67.23 Million USD |
| MarketWatch | $67.23 Million USD |
| marketcap.company | $67.23 Million USD |
| Reuters | $67.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more